Cargando…
Association of Statin Use and Mortality After Transcatheter Aortic Valve Replacement
BACKGROUND: Statins may reduce mortality after transcatheter aortic valve replacement (TAVR) through prevention of atherosclerotic events or pleiotropic effects. However, the competing mortality risks in TAVR patients may dilute any positive effect of statins. We sought to understand the association...
Autores principales: | Peri‐Okonny, Poghni A., Liu, Yangbo, Malaisrie, S. Chris, Huded, Chetan P., Kapadia, Samir, Thourani, Vinod H., Kodali, Susheel K., Webb, John, McAndrew, Thomas C., Leon, Martin B., Cohen, David J., Arnold, Suzanne V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507186/ https://www.ncbi.nlm.nih.gov/pubmed/30947591 http://dx.doi.org/10.1161/JAHA.118.011529 |
Ejemplares similares
-
Transcatheter Aortic Valve Replacement in Intermediate‐ and Low‐Risk Patients
por: Rogers, Toby, et al.
Publicado: (2018) -
Commentary: Accomplishing mission impossible: Transcatheter mitral valve-in-valve replacement for failing intra-atrial bioprosthetic mitral valves
por: Magruder, J. Trent, et al.
Publicado: (2021) -
Economics of Minimalist Transcatheter Aortic Valve Replacement: Results From the 3M-TAVR Economic Study
por: Butala, Neel M., et al.
Publicado: (2022) -
Transcatheter aortic valve replacement for bicuspid aortic valve disease: does conventional surgery have a future?
por: Yeats, Breandan B., et al.
Publicado: (2022) -
Cautious Optimism Regarding Early Transcatheter Aortic Valve Replacement
por: Abdelfattah, Omar M., et al.
Publicado: (2022)